2009-12-18 13:30:15 -

Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, announced today that it is setting up Niacinamide and 3-Cyanopyridine plant of 10,000 TPA each, expected to be ready by end of 2010.

Jubilant is currently ranked amongst the top three manufacturers of Niacin & Niacinamide (Vitamin B3) worldwide and is the only manufacturer of Niacinamide with complete backward integration to the basic feed-stock. Jubilant is also the largest producer of Beta Picoline globally, a critical raw material for the manufacture of Vitamin B3.


Commenting on the development Mr. Pramod Yadav, CEO (Advance Intermediates & Vitamins) of Jubilant Organosys said “Our decision to set up a new facility for Niacinamide reflects our commitment

to our customers and Vitamin B3 Market. Through our in-house research we have developed a very cost efficient and environmental friendly process for the manufacture of these products which will translate into value for our customers. We believe with our new capacity we will strengthen our relationship with the existing wide spread customers globally as well as develop new markets.”

The Niacin/Niacinamide is an important life science ingredient that finds extensive usage in Human Nutrition (flour fortification, food enrichment, multi-vitamins), Animal Nutrition (poultry, dairy and pigs), pharmaceuticals (diabetes and cholesterol drugs) and manufacture of many life science intermediates. 3-Cyanopyridine is an intermediate for the manufacture of Niacinamide, which is also used extensively in the manufacture of various Life Science intermediates used for the production of Pharmaceuticals and Agrochemicals.


About Jubilant Organosys

Jubilant Organosys Ltd., an integrated pharmaceutical industry player, is India's largest Custom Research and Manufacturing Services company (CRAMS) and a leading Drug Discovery and Development Solution Provider.

The company has a presence across the pharmaceutical value chain for providing products and services such as proprietary products, exclusive synthesis, active pharmaceutical ingredients, contract manufacturing of sterile injectables & non-steriles products, radiopharmaceuticals, generic dosage forms, drug discovery services, medicinal chemistry services, clinical research services, and Health Care. The Company also manufactures Industrial and Performance products. www.jubl.com :

Disclaimer.

Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential product characteristics and uses, product sales potential and target dates for product launch are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results.
Actual results may differ materially from those anticipated in the forward-looking statements. Jubilant Organosys may, from time to time, make additional written and oral forward looking statements, including statements contained in the company’s filings with the regulatory bodies and our reports to shareholders. The company assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors


Jubilant Organosys LimitedPramod Yadav+91-120-4361204 pramod_yadav@jubl.com : mailto:pramod_yadav@jubl.com